Stanley Capital Partners Announces Launch of Leading Digital Capabilities With Creation of SCP Digital

Stanley Capital Partners has recently created SCP Digital, which will offer AI, automation, and technological consultancy services to SCP’s portfolio as well as non-SCP clients. The creation of SCP Digital is supported by significant investment from Stanley Capital Partners as the General Partner and involves merging three existing businesses to form a global market-leading platform.

Stanley Capital Partners (SCP) has announced the creation of SCP Digital, which is a leading intelligent automation and Artificial Intelligence technology consultancy. With over 85 professionals operating across the EU, US, and LATAM, SCP Digital will provide digital transformation services to SCP’s portfolio and non-SCP clients, including Telefonica, VW, and Williams Lea. Seeded with the existing S-Labs platform, SCP Digital will operate independently from SCP and is poised to establish a truly global market-leading AI, pure play digital/automation, and transformational consultancy.

SCP Digital has a highly experienced management team that has worked together for more than 20 years and served an extensive blue-chip client list. The creation of SCP Digital represents a significant and sustainable competitive digital advantage for SCP’s own investments, from initial diligence to post-acquisition assessment and ultimately the implementation of transformational growth plans. SCP Digital has already generated a system-wide, perpetuating impact across the entire portfolio, taking portfolio companies from “good to great.”

SCP Digital’s value add was validated by SCP’s 2022 exit of Noden Pharma for an outstanding 6.7x/151% IRR (gross). Noden was acquired in September 2020 with SCP Digital’s support to consolidate the mature-product Speciality Pharma marketplace. SCP’s total investment track record to date across 27 deals and with ~$4.1bn equity invested is 3.3x MOIC/85% IRR. SCP Digital’s capabilities enabled SCP to complete five bolt-on acquisitions for Qinecsa and Laboratoire X.O, which enabled Qinecsa to become a technology-enabled pharmacovigilance company and Laboratoire X.O to internationalize its Speciality Pharma platform.

SCP Digital has helped SCP identify attractive relative value in growth assets and supports Stanley’s ability to buy well in highly attractive growth markets. The creation of SCP Digital represents a game-changing opportunity for SCP in terms of accelerating the transformation of portfolio companies and its own growth. SCP looks forward to continuing the successes of 2022 with a strong platform and pipeline for further growth, targeting an existing $3bn pipeline of potential deal activity.